{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:19:56Z","timestamp":1792657196332,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.clindermatol.2007.08.015","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T01:52:11Z","timestamp":1196473931000},"page":"606-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":295,"title":["Triggering psoriasis: the role of infections and medications"],"prefix":"10.1016","volume":"25","author":[{"given":"Lionel","family":"Fry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2007.08.015_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/rhe1.1955.1.issue-1-4.15","article-title":"Significance of infections in origin of psoriasis","volume":"1","author":"Norrlind","year":"1955","journal-title":"Acta Rheumatol Scand"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib2","series-title":"Recent advances in streptococci and streptococcal diseases","first-page":"334","article-title":"Beta haemolytic streptococcal types associated with psoriasis","author":"Belew","year":"1985"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1992.01680110049004","article-title":"The role of streptococcal infection in the initiation of guttate psoriasis","volume":"128","author":"Telfer","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib4","first-page":"282","article-title":"A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of the disease","volume":"140","author":"Tervaert","year":"1970","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1998.00084.x","article-title":"Tonsillitis and chronic psoriasis","volume":"23","author":"Wardrop","year":"1998","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2133.2003.05552.x","article-title":"Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study","volume":"149","author":"Gudjonsson","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00005537-199705000-00016","article-title":"Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis","volume":"107","author":"Osterlund","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1369-5274(99)80010-1","article-title":"Streptococcal invasion","volume":"2","author":"Molinari","year":"1999","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib9","first-page":"399","article-title":"Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis","volume":"15","author":"Rantakokko","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1017\/S0022215100082694","article-title":"Improvement of recalcitrant psoriasis vulgaris after tonsillectomy","volume":"90","author":"Nyfors","year":"1976","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2273.1996.tb01108.x","article-title":"Clearance of recalcitrant psoriasis after tonsillectomy","volume":"21","author":"Hone","year":"1996","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00403-005-0559-7","article-title":"Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR","volume":"296","author":"Weisenseel","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib14","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-3476(88)80577-8","article-title":"Gutatte psoriasis associated with perianal streptococcal disease","volume":"113","author":"Honig","year":"1988","journal-title":"J Paediatr"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.181.2.747","article-title":"Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin-12 production","volume":"181","author":"Leung","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib17","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI118263","article-title":"Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis","volume":"96","author":"Leung","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib18","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.4049\/jimmunol.176.11.7104","article-title":"Identical T-cell receptor \u03b2-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris","volume":"176","author":"Diluvio","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2000.00919.x","article-title":"Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis","volume":"114","author":"Brown","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004030100218","article-title":"Non-M protein on the cell wall and membrane of group A streptococci induces IFN-\u03b3 production by dermal CD4+ T cells in psoriasis","volume":"293","author":"Brown","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-3083.2003.01309.x","article-title":"Selective response of dermal Th-1 cells to 20-50 kDa streptococcal cell wall proteins in chronic plaque psoriasis","volume":"58","author":"Baker","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/path.1954","article-title":"Peptidoglycan and peptidoglycan-specific Th-1 cells in psoriasis lesions","volume":"209","author":"Baker","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2249.1999.01013.x","article-title":"Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?","volume":"117","author":"Gudmundsdottir","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2005.01.001","article-title":"HLA-DR B1*04, *07-restricted epitopes on keratin 17 for autoreactive T cells in psoriasis","volume":"38","author":"Shen","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.2004.00600.x","article-title":"Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8+ T cells","volume":"138","author":"Johnston","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1172\/JCI116711","article-title":"Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens","volume":"92","author":"Leung","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1099\/0022-1317-51-10-808","article-title":"Secondary bacterial infections complicating skin lesions","volume":"51","author":"Brook","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaad.2005.02.034","article-title":"Staphylococcal toxins in patients with psoriasis, atopic dermatitis and erythroderma, and in healthy control subjects","volume":"53","author":"Tomi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI6835","article-title":"Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis","volume":"104","author":"Travers","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib31","first-page":"310","article-title":"HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harbouring toxin-producing Staphylococcus aureus","volume":"4","author":"Ajib","year":"2005","journal-title":"J Biomed Biotech"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(85)90853-0","article-title":"Response of scalp psoriasis to oral ketoconazole","volume":"2","author":"Farr","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.1982.01650180004002","article-title":"Improvement of psoriasis of the scalp with ketoconazole","volume":"118","author":"Rosenberg","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archderm.1982.01650170036019","article-title":"Patch tests with killed sonicated microflora in patients with psoriasis","volume":"118","author":"Lober","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archderm.1990.01670320135037","article-title":"Does Pityrosporum ovale have a role in psoriasis?","volume":"126","author":"Elewski","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2340\/00015555761012","article-title":"Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients","volume":"76","author":"Bunse","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2249.1996.d01-719.x","article-title":"Antibodies from patients with psoriasis recognise N-acetyl-glucosamine terminals in glycoproteins from Pityrosporum ovale","volume":"105","author":"Mathov","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2133.1997.d01-1192.x","article-title":"Differential reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis","volume":"136","author":"Baker","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.0303-6987.2004.0135.x","article-title":"Possible role of Malassezia furfur in psoriasis: modulation of TGF-\u03b21, integrin and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients","volume":"31","author":"Baroni","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12468941","article-title":"A potential role for superantigens in the pathogenesis of psoriasis","volume":"100","author":"Leung","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/myc.1990.33.2.90","article-title":"Fungal flora of human faeces in psoriasis and atopic dermatitis","volume":"33","author":"Buslau","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/myc.1990.33.1.29","article-title":"Studies on the yeast flora in patients suffering from psoriasis capillitii or seborrheic dermatitis of the scalp","volume":"33","author":"Sneff","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1439-0507.2001.00608.x","article-title":"Incidence of Candida in psoriasis\u2014a study on the fungal flora of psoriatic patients","volume":"44","author":"Waldman","year":"2001","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib44","first-page":"611","article-title":"The significance of yeasts in seborrheic dermatitis","volume":"40","author":"Buslau","year":"1989","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1747.1998.00164.x","article-title":"Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis","volume":"110","author":"Favre","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1523-1747.1999.00641.x","article-title":"High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA","volume":"133","author":"Wiessenborn","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1523-1747.1998.00310.x","article-title":"Is human papillomavirus type 5 the putative autoantigen involved in psoriasis?","volume":"111","author":"Majewski","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1999.00536.x","article-title":"A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17 qter in a region containing a psoriasis locus","volume":"112","author":"Ramoz","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib49","first-page":"221","article-title":"A virus-like particle associated with psoriasis","volume":"91","author":"Dalen","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand [B]"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib50","first-page":"413","article-title":"Characterisation of virus-like particles from a psoriatic patient with respect to the possible presence of particle-associated RNA and RNA-directed DNA polymerase","volume":"91","author":"Iversen","year":"1983","journal-title":"Acta Pathol Microbiol Immunol. Scand [B]"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib51","series-title":"Psoriasis","first-page":"251","article-title":"Virological studies on psoriatic lymphocytes","author":"Guilhou","year":"1982"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1702(03)00137-0","article-title":"High prevalence of an IgG response against murine leukaemia virus (MLV) in patients with psoriasis","volume":"94","author":"Mol\u00e9s","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib53","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archderm.1987.01660360050012","article-title":"Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome","volume":"123","author":"Duvic","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib54","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1126\/science.3201255","article-title":"Development of disease and virus recovery in transgenic mice containing HIV proviral DNA","volume":"242","author":"Leonard","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365540500322296","article-title":"Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy","volume":"38","author":"De Socio","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/08916930310001637986","article-title":"Paradoxical exacerbation of psoriasis in AIDS: proposed explanations including the potential roles of substance P and Gram-negative bacteria","volume":"37","author":"Namazi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib57","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0190-9622(03)02540-4","article-title":"Human endogenous retroviruses and their possible impact on dermatology","volume":"52","author":"Rebora","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.1999.00728.x","article-title":"Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation","volume":"113","author":"Hohenadl","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/1523-1747.ep12329612","article-title":"Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands","volume":"106","author":"Andersson","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2005.06555.x","article-title":"A new endogenous retroviral sequence is expressed in skin of patients with psoriasis","volume":"153","author":"Mol\u00e8s","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.2004.06116.x","article-title":"Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin","volume":"151","author":"Bessis","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib62","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/CDLI.6.6.783-786.1999","article-title":"Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients","volume":"6","author":"Stevens","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/1096-9071(200012)62:4<435::AID-JMV7>3.0.CO;2-R","article-title":"Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons","volume":"62","author":"Lawoko","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.0022-202X.2004.23504.x","article-title":"Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis","volume":"124","author":"Foerster","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s001050050460","article-title":"Endogenous retroviral sequences as a factor in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Walchner","year":"1996","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib66","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0190-9622(86)70265-X","article-title":"Drugs in exacerbation of psoriasis","volume":"15","author":"Abel","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0033-3182(72)71404-8","article-title":"The relationship of lithium carbonate to psoriasis","volume":"13","author":"Carter","year":"1972","journal-title":"Psychosomatics"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0033-3182(76)71133-2","article-title":"More about the relationship of lithium to psoriasis","volume":"17","author":"Bakker","year":"1976","journal-title":"Psychosomatics"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib69","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archderm.1979.04010100005003","article-title":"Lithium compound treatment and psoriasis","volume":"115","author":"Skoven","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.143.1.42","article-title":"A review and controlled study of cutaneous conditions associated with lithium carbonate","volume":"143","author":"Sarantidis","year":"1983","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib71","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0190-9622(82)70147-1","article-title":"Palmoplantar pustular psoriasis provoked by lithium therapy","volume":"7","author":"White","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug induced psoriasis: recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00128071-200405010-00002","article-title":"Cutaneous adverse effects of lithium: epidemiology and management","volume":"5","author":"Yeung","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib74","first-page":"35","article-title":"Lithium induced psoriasiform dermatitis","volume":"10","author":"Fox","year":"1984","journal-title":"J Assoc Military Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib75","first-page":"19","article-title":"Manifestations cutan\u00e9es des therapeutiques par le lithium","volume":"109","author":"Lambert","year":"1982","journal-title":"Am Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib76","first-page":"217","article-title":"Tyrosine phosphorylation in psoriasis T cells is modified by drugs that induce or improve psoriasis","volume":"191","author":"Ockenfels","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib77","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1107\/S0907444905004038","article-title":"High resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy","volume":"61","author":"Gill","year":"2005","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib78","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2133.2004.05822.x","article-title":"The effect of inositol supplements on the psoriasis of patients taking lithium: randomised placebo-controlled trial","volume":"150","author":"Allan","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02505220","article-title":"Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium","volume":"288","author":"Ockenfels","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-5618.2005.00214.x","article-title":"Evidence that the immunopathogenic mechanism of lithium induced psoriasis differs from that of regular psoriasis","volume":"7","author":"Knijff","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib81","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4362.1988.tb02419.x","article-title":"Beta-adrenoceptor antagonist-induced psoriasiform eruption","volume":"27","author":"Heng","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.0954-6820.1976.tb06749.x","article-title":"Cutaneous reactions to propranolol (Inderal)","volume":"199","author":"Jenson","year":"1976","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib83","first-page":"95","article-title":"Psoriasiform eruption induced by propranolol","volume":"24","author":"Halvey","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib84","first-page":"181","article-title":"Psoriasis-as side-effect of \u03b2 adrenergic blocking agent\u2014propranolol","volume":"35","author":"Kaur","year":"1983","journal-title":"Indian Heart J"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00015550510032823","article-title":"Drug exposure and psoriasis vulgaris: case-control and case-crossover studies","volume":"85","author":"Cohen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib86","first-page":"426","article-title":"The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis","volume":"5","author":"O'Brien","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib87","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0190-9622(87)80021-X","article-title":"Pustular psoriasis associated with hydroxychloroquine","volume":"16","author":"Friedman","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jid.1956.58","article-title":"Preliminary and short report: action of synthetic anti-malarial drugs on psoriasis","volume":"22","author":"Cornbleet","year":"1956","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib89","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2133.1966.tb12195.x","article-title":"The influence of plaguenil on psoriasis and keratoderma blenorrhagica","volume":"78","author":"Baker","year":"1966","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib90","first-page":"153","article-title":"Effect of anti-malarial drugs on psoriasis","volume":".26","author":"Kuflik","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib91","first-page":"833","article-title":"Anti malarials in psoriatic arthritis","volume":"10","author":"Trnavsky","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15569520500536568","article-title":"Drug induced psoriasis: an evidence based overview and the introduction of psoriatic drug eruption probability score","volume":"25","author":"Dika","year":"2006","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-4362.1997.00002.x","article-title":"Is transglutaminase the mediator between anti malarial drugs and psoriasis","volume":"36","author":"Wolf","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib94","first-page":"362","article-title":"Topical indomethacin exacerbates lesions of psoriasis","volume":"80","author":"Ellis","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib95","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2133.1987.tb07364.x","article-title":"Exacerbation of psoriasis by indomethacin","volume":"117","author":"Powles","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib96","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/j.1365-2230.1989.tb00949.x","article-title":"Psoriasis induced by topically applied indomethacin","volume":"14","author":"Lazarova","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0190-9622(88)70216-9","article-title":"Psoriasis and drugs","volume":"19","author":"Tsankov","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib99","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(81)80125-9","article-title":"Psoriasiform eruption induced by digoxin. Confirmed by re-exposure","volume":"5","author":"David","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/archderm.1981.01650010008011","article-title":"Exacerbation of psoriasis during clonidine therapy","volume":"117","author":"Wilkin","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib101","first-page":"711","article-title":"Amioderone and psoriasis","volume":"95","author":"Muir","year":"1982","journal-title":"N Z Med J"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib102","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(83)80153-4","article-title":"Quinidine induced psoriasis","volume":"9","author":"Harwell","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/106002809202600215","article-title":"Fluoxetine-induced psoriasis","volume":"26","author":"Hemlock","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib104","first-page":"283","article-title":"Psoriasiform eruption induced by anticonvulsants","volume":"30","author":"Brenner","year":"1994","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib105","first-page":"404","article-title":"Psoriasis during therapy with olanzapine","volume":"13","author":"Latini","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib106","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0190-9622(87)70281-3","article-title":"Penicillin-induced generalised pustular psoriasis","volume":"17","author":"Katz","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2230.2000.00592.x","article-title":"Generalised pustular psoriasis or drug induced pustulo derma. The use of patch testing","volume":"25","author":"Whittan","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib108","first-page":"387","article-title":"Acute generalised exanthematous pustulosis","volume":"44","author":"Epelbaum","year":"1989","journal-title":"Pediatric"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib109","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by alpha-interferon","volume":"1254","author":"Funk","year":"1991","journal-title":"Br J Dematol"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib110","first-page":"2903","article-title":"Activation of psoriasis in patients undergoing treatment with \u03b2-interferon","volume":"167","author":"Navne","year":"2005","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib111","doi-asserted-by":"crossref","unstructured":"Fanti PA, Dika E, Vaccari S, et al. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006;45:1464-5.","DOI":"10.1111\/j.1365-4632.2006.02980.x"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib112","first-page":"132","article-title":"Exacerbation of psoriasis during treatment with H2 antagonists","volume":"153","author":"Andersen","year":"1991","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.clindermatol.2007.08.015_bib113","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.1988.01670060012006","article-title":"Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil","volume":"124","author":"Fisher","year":"1988","journal-title":"Arch Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:34:32Z","timestamp":1783348472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X07001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0738081X07001599"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.015","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triggering psoriasis: the role of infections and medications","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}